If you liked this article you might like

Blood Work: A Few Biotech Thoughts from Sunny San Diego and the ASH 2016 Meeting
Patient Deaths, Safety Concerns Cause Juno's CAR-T Pipeline to Skid Out
Bluebird, Celgene T-Cell Therapy Eliminates Multiple Myeloma With Minimal Side Effects
Four Stocks Ready for Breakouts -- Check These Charts